How Russell’s Viper Venom Starts a Clotting Cascade
Blood normally clots only where a vessel is damaged. Russell’s viper venom can short-circuit that control: enzymes in it activate clotting proteins, including factor X, a key switch in the chain of reactions that produces thrombin. Thrombin then helps turn soluble fibrinogen into fibrin, the strands that form a clot’s supporting mesh.
The result is not simply a useful plug forming wherever one is needed. Venom spreads through the bloodstream, triggering clotting across many sites. As those reactions consume clotting proteins and fibrinogen, the blood can lose its ability to clot effectively. A person may therefore suffer both dangerous clot formation and severe bleeding—a condition called venom-induced consumption coagulopathy.
Why the Same Chemistry Can Be Useful
The difference between harm and benefit is control. In a laboratory, a measured amount of a purified venom component can trigger a specific step in clotting tests, helping clinicians assess how the clotting system is working. In a surgical setting, a clot-promoting agent is useful only if its action can be confined and appropriately dosed; uncontrolled activation throughout the circulation is the danger, not the treatment.
That distinction is the striking lesson of the venom: a clotting reaction is not automatically protective. Its effect depends on where it starts, how much of the reaction it triggers, and whether the body retains enough clotting material to seal an actual wound.
